Ischemia Care
PrivateLast Round
Grant
Sep 23, 2019
Total Funding Raised
$25,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ischemia Care is a diagnostics company that develops and commercializes RNA expression-based blood tests to identify the cause of ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ischemia Care Comparables
Compare Ischemia Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galaxy CCRO, Inc. | 76% | |
| Astria Biosciences, Inc. | 69% | |
| ABCDx | 69% |
Ischemia Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2019 | ||||
| VC Round | Dec 31, 2018 |
Ischemia Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Early Stage Partners | VC Round |
| MedTech Innovator | Grant |
| QCA Ventures | VC Round |
| RC Capital | VC Round |
| AdvaMed Accel | Grant |
| Broadview Ventures | VC Round |
| Solas BioVentures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 61% MoM, from 1.6K to 2.6K.
- Jan 21, 2026
Monthly visitors grew 62% MoM.
Ischemia Care Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ischemia Care's valuation, stock price, and market status.
Is Ischemia Care a public or private company?
Ischemia Care is a private company.
What is the current stock price of Ischemia Care?
Ischemia Care is a private company, so its shares have no public market price. Caplight tracks Ischemia Care's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ischemia Care worth (valuation)?
Valuation information for Ischemia Care is not publicly available.
Can I buy Ischemia Care stock?
Ischemia Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ischemia Care's last funding round?
Ischemia Care's most recent funding round was Grant on September 23, 2019.
Who are the main investors in Ischemia Care?
Key investors in Ischemia Care include Early Stage Partners, MedTech Innovator, QCA Ventures, RC Capital, AdvaMed Accel.
Will Ischemia Care IPO soon?
No public IPO plans have been announced for Ischemia Care.
How can I track Ischemia Care secondary market activity?
Caplight tracks bids, offers, and trades in Ischemia Care's shares on secondary markets.